Argonaut Technologies has introduced a new resin-bound reagent, MP-TsO-TEMPO that enables medicinal chemists to introduce diversity into chemical libraries with high purity and yields.
Jeff Labadie, vice president for chemistry products at Argonaut, is scheduled to present results obtained using MP-TsO-TEMPO resin at the 2nd European Symposium on Combinatorial Sciences being held in Copenhagen, Denmark, from 29 June to 3 July.
Argonaut said that the resin-bound reagent eliminates the need to undertake cumbersome purification steps, thereby improving yields of target compounds and intermediates.